Pharmafile Logo

real-time data

regeneron headquarters

Regeneron’s Lynozyfic granted FDA accelerated approval to treat multiple myeloma

More than 36,000 new cases of the blood cancer are expected to be diagnosed in the US this year

- PMLiVE

The Considered appoints Tina Bertolini as chief client services officer

Bertolini most recently served as the agency’s head of client services and operations

- PMLiVE

Alzheimer’s disease – the silent pandemic and the positive impact of AI

Using AI, future eye exams could be used to detect early signs of Alzheimer’s and heart disease

Mother playing with son

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

Cuttsy + Cuttsy

- PMLiVE

Communiqué 2025: celebrating excellence in healthcare communications

This year’s Awards, held at the Grosvenor House Hotel in London on 3 July, included 30 categories

- PMLiVE

UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

- PMLiVE

Beyond the badge: communicating the business case for DEI

Progress takes commitment, courage and action

- PMLiVE

AbbVie to expand immunology capabilities with $2.1bn Capstan acquisition

The deal includes a CAR-T therapy in phase 1 development for B cell-mediated autoimmune diseases

- PMLiVE

Avalere Health appoints Saiqa Khan as head of growth

Khan most recently served as executive vice president, head of commercial development at Complete HealthVizion

- PMLiVE

ASCO 2025 – bringing a sense of urgency to the war against cancer

‘Hot’ tumours, breast cancer breakthroughs and holistic treatment were the standouts at this year’s event

people hold signs with speech bubbles

The importance of appropriate language when raising awareness of a disease

Using the right language in disease awareness campaigns can help help save lives. Here we share top tips on how to use language that is accessible, inclusive and engaging.

Say Communications

- PMLiVE

UCB shares promising results for fenfluramine in ultra-rare form of epilepsy

CDKL5 deficiency disorder occurs in approximately one in 40,000 to 60,000 live births

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links